These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 13968454)

  • 1. Vincristine in the treatment of lymphomas and leukemias.
    BOHANNON RA; MILLER DG; DIAMOND HD
    Cancer Res; 1963 May; 23():613-21. PubMed ID: 13968454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protein equilibrium during splenohematic syndromes].
    GEOFFROY H; TAHIRI A
    Maroc Med; 1962 May; 41():498-509. PubMed ID: 13897739
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin manifestations of leukemias and lymphomas.
    Stawiski MA
    Cutis; 1978 Jun; 21(6):814-8. PubMed ID: 275026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABNORMAL KARYOTYPE FINDINGS IN BONE MARROW AND LYMPH NODE ASPIRATES OF A PATIENT WITH MALIGNANT LYMPHOMA.
    TJIO JH; MARSH JC; WHANG J; FREI F
    Blood; 1963 Aug; 22():178-90. PubMed ID: 14045302
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE ARTICULAR MANIFESTATIONS OF CHRONIC BLOOD DISEASES].
    GUERIN C
    Rev Rhum Mal Osteoartic; 1963 Dec; 30():841-2. PubMed ID: 14116408
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of malignancies of the reticuloendothelial system.
    GHRIST TD
    J Iowa State Med Soc; 1963 Feb; 53():72-82. PubMed ID: 13947558
    [No Abstract]   [Full Text] [Related]  

  • 7. PRODUCTION OF ANTIBODIES AGAINST VIRUSES IN LEUKAEMIA AND RELATED DISEASES.
    HEATH RB; FAIRLEY GH; MALPAS JS
    Br J Haematol; 1964 Jul; 10():365-70. PubMed ID: 14179491
    [No Abstract]   [Full Text] [Related]  

  • 8. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. II. BLOOD COMPLEMENT VALUES IN LEUKAEMIA, MALIGNANT LYMPHOMA, AND MYELOMA.
    LIBANSKY J; JEZKOVA Z
    Neoplasma; 1963; 10():605-19. PubMed ID: 14103648
    [No Abstract]   [Full Text] [Related]  

  • 9. [ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
    MATHE G; SCHNEIDER M; CATTAN A; AMIEL JL; SCHWARZENBERG L; SCHLUMBERGER JR
    Rev Fr Etud Clin Biol; 1964 Nov; 9():990-2. PubMed ID: 14232681
    [No Abstract]   [Full Text] [Related]  

  • 10. [RADIOTHERAPY OF BLOOD DISEASES].
    CAPUA A
    Riforma Med; 1964 May; 78():573-82. PubMed ID: 14170522
    [No Abstract]   [Full Text] [Related]  

  • 11. [VARIATIONS IN SERUM COPPER OXIDASE (CERULOPLASMIN) IN THE COURSE OF MALIGNANT LYMPHOGRANULOMATOSIS].
    ZAMFIRESCU-GHEORGHIU M; PETRESCU M; GROZEA P; GOCIU M; SIGHETEA E; VLADESCU C; CUCU F
    Stud Cercet Med Interna; 1964; 5(3):263-7. PubMed ID: 14203689
    [No Abstract]   [Full Text] [Related]  

  • 12. 5 YEARS EXPERIENCE WITH DIFFERENT N-LOST-PHOSPHAMIDESTERS IN TUMOR CHEMOTHERAPY.
    GROSS R
    Acta Unio Int Contra Cancrum; 1964; 20():369-72. PubMed ID: 14151932
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Hodgkin's disease and the leukemias with cytoxan. II. Clinical reports, 1960-62.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1962 Aug; 134():305-12. PubMed ID: 13976140
    [No Abstract]   [Full Text] [Related]  

  • 14. THE LOCAL INFLAMMATORY RESPONSE IN PATIENTS WITH BLOOD DYSCRASIAS AS TESTED BY THE SKIN WINDOW TECHNIQUE.
    WEBER RE; HELMAN N
    Bull Sinai Hosp Detroit; 1963; 11():95-9. PubMed ID: 14064458
    [No Abstract]   [Full Text] [Related]  

  • 15. [TUBERCULIN ANERGY AS A CRITERION OF BIOLOGICAL DELIMITATION OF MALIGNANT RETICULOPATHIES].
    POPA M; POPA G; VEIZA L
    Med Interna (Bucur); 1964 Jul; 16():811-8. PubMed ID: 14182762
    [No Abstract]   [Full Text] [Related]  

  • 16. TRIETHYLENE MELAMINE IN THE CONTROL OF HODGKIN'S DISEASE AND THE LEUKEMIAS. IV. CLINICAL REPORTS, 1959-62.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1963 Dec; 135():451-7. PubMed ID: 14101404
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDY OF IMMUNOLOGIC REACTIVITY IN HEMOBLASTOSIS. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.
    LIBANSKY J
    Blood; 1965 Feb; 25():169-78. PubMed ID: 14267693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES ON THE TREATMENT OF MALIGNANT TUMORS WITH FIBROBLAST-INHIBITING AGENT. IV. EFFECTS OF CHLOROQUINE ON MALIGNANT LYMPHOMAS.
    HIRAKI K; KIMURA I
    Acta Med Okayama (1952); 1964 Apr; 18():87-92. PubMed ID: 14204462
    [No Abstract]   [Full Text] [Related]  

  • 20. [STIMULATION OF NEUTROPHILIA BY A POLYSACCHARIDE EXTRACT OF "VISCUM ALBUM". ITS THERAPEUTIC USE IN NEUTROPENIA].
    MATHE G; SCHNEIDER M; AMIEL JL; CATTAN A; SCHWARZENBERG L; BERNO M
    Rev Fr Etud Clin Biol; 1963 Dec; 8():1017-20. PubMed ID: 14102503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.